tirzepatide 22 mg-4 mg/ml Bk-Tirzepatide Tirzepatide / Niacinamide Injection |

This is natural and expected

Each kilogram of weight loss typically reduces systolic blood pressure by approximately 1 mmHg, and some studies show even greater improvements in individuals with obesity

Results may be subtle or gradual A few users report little to no noticeable change or slower-than-expected effects

While the medications themselves do not appear to cause blood clots, certain patient characteristics significantly elevate baseline thrombotic risk

Given the strong association between HS, obesity, and metabolic syndrome, these agents may offer therapeutic benefit through their anti-inflammatory and metabolic effects